Matches in Wikidata for { <http://www.wikidata.org/entity/Q34021957> ?p ?o ?g. }
- Q34021957 description "2010 nî lūn-bûn" @default.
- Q34021957 description "2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q34021957 description "2010 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q34021957 description "2010年の論文" @default.
- Q34021957 description "2010年論文" @default.
- Q34021957 description "2010年論文" @default.
- Q34021957 description "2010年論文" @default.
- Q34021957 description "2010年論文" @default.
- Q34021957 description "2010年論文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010年论文" @default.
- Q34021957 description "2010년 논문" @default.
- Q34021957 description "article científic" @default.
- Q34021957 description "article scientific" @default.
- Q34021957 description "article scientifique (publié 2010)" @default.
- Q34021957 description "articol științific" @default.
- Q34021957 description "articolo scientifico" @default.
- Q34021957 description "artigo científico (publicado na 2010)" @default.
- Q34021957 description "artigo científico (publicado na 2010)" @default.
- Q34021957 description "artigo científico" @default.
- Q34021957 description "artikull shkencor" @default.
- Q34021957 description "artikulong pang-agham" @default.
- Q34021957 description "artykuł naukowy" @default.
- Q34021957 description "artículo científico publicado en 2010" @default.
- Q34021957 description "artículu científicu espublizáu en 2010" @default.
- Q34021957 description "bilimsel makale" @default.
- Q34021957 description "bài báo khoa học" @default.
- Q34021957 description "mokslinis straipsnis" @default.
- Q34021957 description "naučni članak" @default.
- Q34021957 description "scienca artikolo" @default.
- Q34021957 description "scientific article" @default.
- Q34021957 description "teaduslik artikkel" @default.
- Q34021957 description "tieteellinen artikkeli" @default.
- Q34021957 description "tudományos cikk" @default.
- Q34021957 description "vedecký článok" @default.
- Q34021957 description "vetenskaplig artikel" @default.
- Q34021957 description "videnskabelig artikel (udgivet 2010)" @default.
- Q34021957 description "vitenskapelig artikkel" @default.
- Q34021957 description "vitskapeleg artikkel" @default.
- Q34021957 description "vědecký článek" @default.
- Q34021957 description "wetenschappelijk artikel" @default.
- Q34021957 description "wissenschaftlicher Artikel" @default.
- Q34021957 description "επιστημονικό άρθρο" @default.
- Q34021957 description "мақолаи илмӣ" @default.
- Q34021957 description "мақолаи илмӣ" @default.
- Q34021957 description "наукова стаття, опублікована у квітні 2010" @default.
- Q34021957 description "научна статия" @default.
- Q34021957 description "научная статья" @default.
- Q34021957 description "научни чланак" @default.
- Q34021957 description "научни чланак" @default.
- Q34021957 description "מאמר מדעי" @default.
- Q34021957 description "سائنسی مضمون" @default.
- Q34021957 description "مقالة علمية" @default.
- Q34021957 description "مقالهٔ علمی" @default.
- Q34021957 description "২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34021957 description "บทความทางวิทยาศาสตร์" @default.
- Q34021957 description "სამეცნიერო სტატია" @default.
- Q34021957 name "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 name "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 name "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma" @default.
- Q34021957 type Item @default.
- Q34021957 label "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 label "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 label "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma" @default.
- Q34021957 prefLabel "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 prefLabel "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.
- Q34021957 prefLabel "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma" @default.
- Q34021957 P1433 Q34021957-8726D8E6-73EE-4281-9888-0DDB7AFE44C3 @default.
- Q34021957 P1476 Q34021957-2C3C5B0C-770E-440A-8608-FC85CA5309C7 @default.
- Q34021957 P2093 Q34021957-0B9251B4-87E8-4F44-A2FD-080C3C5E36B1 @default.
- Q34021957 P2093 Q34021957-4107949B-30A9-404C-91D3-BC4C4F25C0C0 @default.
- Q34021957 P2093 Q34021957-6EBD2F9C-290E-4AC5-9170-7D5FD2B521DA @default.
- Q34021957 P2093 Q34021957-81F9FE3A-4C1E-410F-81A3-482C54E0917A @default.
- Q34021957 P2093 Q34021957-B826C43E-F55C-4EB9-AA00-EAD8F3AFCF6D @default.
- Q34021957 P2093 Q34021957-C90039A7-E5A8-428E-97DC-7FAC1A762CD5 @default.
- Q34021957 P2093 Q34021957-E796111F-4B24-4A41-91F3-3A833413668E @default.
- Q34021957 P2093 Q34021957-F5CB911A-E274-42AD-B330-DAF6E65A0A6A @default.
- Q34021957 P2093 Q34021957-FC067552-6A82-4F87-8890-FE5FAD2A15F6 @default.
- Q34021957 P304 Q34021957-FE161EE1-776C-42D5-9FC4-789BC6D61A8E @default.
- Q34021957 P31 Q34021957-9A016F1A-94E8-4E83-955A-E779F0FC8275 @default.
- Q34021957 P356 Q34021957-2435BB7B-4775-427B-B64B-FBB5FB213A27 @default.
- Q34021957 P407 Q34021957-56F3B28B-6BA8-4452-9F5F-A4D16D4A2A1C @default.
- Q34021957 P433 Q34021957-378ADEB6-7618-4211-BA12-B83504E1CD94 @default.
- Q34021957 P478 Q34021957-71280D5C-C59E-4687-A7AF-28D961F30810 @default.
- Q34021957 P50 Q34021957-83FC581E-4E47-4BB0-B23F-6369BAC2B332 @default.
- Q34021957 P577 Q34021957-E9B23EEC-5836-4DEC-A68B-F1F4B1FEEE8F @default.
- Q34021957 P698 Q34021957-57A4A8BF-1FE8-4D43-A42C-82F217F0ABDA @default.
- Q34021957 P921 Q34021957-00653615-A53A-4FEA-BD3C-80BDD544FE23 @default.
- Q34021957 P921 Q34021957-2766AA8C-FB2B-4658-9090-5E1E7862CAC2 @default.
- Q34021957 P921 Q34021957-5797293D-76A2-4058-B9B8-8A49F374D6A3 @default.
- Q34021957 P921 Q34021957-8BA9CBFB-C8D4-4851-A78F-04F0FF3F41DE @default.
- Q34021957 P921 Q34021957-F3D19468-23FC-45FA-8FD3-EBBEC97A4356 @default.
- Q34021957 P356 JCO.2009.26.7849 @default.
- Q34021957 P698 20368553 @default.
- Q34021957 P1433 Q400292 @default.
- Q34021957 P1476 "Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival" @default.